Phase II Trials of Erlotinib or Gefitinib in Patients with Recurrent Meningioma

There are no established treatments for recurrent meningioma when surgical and radiation options are exhausted. The epidermal growth factor receptor (EGFR) is often over-expressed in meningiomas and may promote tumor growth. In open label, single arm phase II studies of the EGFR inhibitors gefitinib...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Norden, Andrew D., Raizer, Jeffrey J., Abrey, Lauren E., Lamborn, Kathleen R., Lassman, Andrew B., Chang, Susan M., Yung, W.K. Alfred, Gilbert, Mark R., Fine, Howard A., Mehta, Minesh, DeAngelis, Lisa M., Cloughesy, Timothy F., Robins, H. Ian, Aldape, Kenneth, Dancey, Janet, Prados, Michael D., Lieberman, Frank, Wen, Patrick Y.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3786190/
https://ncbi.nlm.nih.gov/pubmed/19562255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-009-9948-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados